Intervention Protocol

Nasal decongestants for the common cold

  1. Shayan H Ta'i1,*,
  2. Kylie AM Ferguson1,
  3. Harsheel K Singh1,
  4. Atul N Sharma1,
  5. Shilpa Kumar1,
  6. Mieke L van Driel1,2,3,
  7. An IM De Sutter3,4

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 15 FEB 2012

DOI: 10.1002/14651858.CD009612

How to Cite

Ta'i SH, Ferguson KAM, Singh HK, Sharma AN, Kumar S, van Driel ML, De Sutter AIM. Nasal decongestants for the common cold (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009612. DOI: 10.1002/14651858.CD009612.

Author Information

  1. 1

    Bond University, Faculty of Health Sciences and Medicine, Gold Coast, Queensland, Australia

  2. 2

    The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Queensland, Australia

  3. 3

    Ghent University, Department of General Practice and Primary Health Care, Ghent, Belgium

  4. 4

    Ghent University, Heymans Institute of Pharmacology, Ghent, Belgium

*Shayan H Ta'i, Faculty of Health Sciences and Medicine, Bond University, University Drive, Robina, Gold Coast, Queensland, 4229, Australia.

Publication History

  1. Publication Status: New
  2. Published Online: 15 FEB 2012




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To determine the efficacy of nasal decongestants in the common cold compared with placebo, in children and adults.
  2. To identify the possible adverse effects associated with short-term and long-term use of nasal decongestants.